Non-surgical management of erectile dysfunction

被引:17
作者
Levy, A
Crowley, T
Gingell, C
机构
[1] Univ Bristol, Bristol Royal Infirm, Div Med, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England
[2] Southmead Hosp, Dept Urol, Bristol Urol Inst, Bristol, Avon, England
关键词
D O I
10.1046/j.1365-2265.2000.00954.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction is a common and distressing medical condition that is now highly amenable to treatment almost irrespective of the cause. Safe, non-surgical treatments with unequivocal efficacy are psychological therapy, intracorporeal injection of vasoactive drugs, transurethral vasodilators and oral sildenafil, all of which have been reported to have a 50-70% overall response rate. Vacuum constriction devices are acceptable for some, usually older patients and oral yohimbine is thought to have marginal efficacy. Local creams to induce or enhance erectile function are currently being investigated. There is no place for androgen supplementation unless the patient is profoundly hypogonadal. Treatment of hyperprolactinaemia is very effective but is a rare cause of erectile dysfunction. As intercourse may entail an unfamiliar level of physical activity, it is sensible to ensure that the patient is able to climb a flight or two of stairs comfortably without provoking undue breathlessness or chest pain and to provide suitable advice about technique before commencing treatment. Once it is clear to the patients that erectile dysfunction can be satisfactorily overcome, the long- term use of treatments to do so tends to wane. Thus, although the prospect of effective treatment for what had been for many a distressing life sentence has the potential to place new demands on the health service, there is no evidence that restrictions on prescribing will prove economically rational.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 105 条
[1]  
ALDRIDGE J, 1999, LANCET, V353, P340
[2]   Neurotransmission and the contraction and relaxation of penile erectile tissues [J].
Andersson, KE ;
Stief, CG .
WORLD JOURNAL OF UROLOGY, 1997, 15 (01) :14-20
[3]   The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study [J].
Araujo, AB ;
Durante, R ;
Feldman, HA ;
Goldstein, I ;
McKinlay, JB .
PSYCHOSOMATIC MEDICINE, 1998, 60 (04) :458-465
[4]   TREATING ERECTILE DYSFUNCTION WITH A VACUUM TUMESCENCE DEVICE - A RETROSPECTIVE ANALYSIS OF ACCEPTANCE AND SATISFACTION [J].
BALTACI, S ;
AYDOS, K ;
KOSAR, A ;
ANAFARTA, K .
BRITISH JOURNAL OF UROLOGY, 1995, 76 (06) :757-760
[5]   Oral phentolamine as treatment for erectile dysfunction [J].
Becker, AJ ;
Stief, CG ;
Machtens, S ;
Schultheiss, D ;
Hartmann, U ;
Truss, MC ;
Jonas, U .
JOURNAL OF UROLOGY, 1998, 159 (04) :1214-1215
[6]   TREATMENT OF MALE ERECTILE DYSFUNCTION USING THE ACTIVE VACUUM ASSIST DEVICE [J].
BODANSKY, HJ .
DIABETIC MEDICINE, 1994, 11 (04) :410-412
[7]   OBJECTIVE MEASUREMENT OF THE EFFECTIVENESS, THERAPEUTIC SUCCESS AND DYNAMIC MECHANISMS OF THE VACUUM DEVICE [J].
BOSSHARDT, RJ ;
FARWERK, R ;
SIKORA, R ;
SOHN, M ;
JAKSE, G .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (06) :786-791
[9]   Nitric oxide in the penis: Physiology and pathology [J].
Burnett, AL .
JOURNAL OF UROLOGY, 1997, 157 (01) :320-324
[10]   Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2 [J].
Burnett, AL ;
Johns, DG ;
Kriegsfeld, LJ ;
Klein, SL ;
Calvin, DC ;
Demas, GE ;
Schramm, LP ;
Nelson, RJ ;
Snyder, SH ;
Poss, KD .
NATURE MEDICINE, 1998, 4 (01) :84-87